Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450*

NADPH-cytochrome P450 oxidoreductase (CYPOR) catalyzes the transfer of electrons to all known microsomal cytochromes P450. A CYPOR variant, with a 4-amino acid deletion in the hinge connecting the FMN domain to the rest of the protein, has been crystallized in three remarkably extended conformations. The variant donates an electron to cytochrome P450 at the same rate as the wild-type, when provided with sufficient electrons. Nevertheless, it is defective in its ability to transfer electrons intramolecularly from FAD to FMN. The three extended CYPOR structures demonstrate that, by pivoting on the C terminus of the hinge, the FMN domain of the enzyme undergoes a structural rearrangement that separates it from FAD and exposes the FMN, allowing it to interact with its redox partners. A similar movement most likely occurs in the wild-type enzyme in the course of transferring electrons from FAD to its physiological partner, cytochrome P450. A model of the complex between an open conformation of CYPOR and cytochrome P450 is presented that satisfies mutagenesis constraints. Neither lengthening the linker nor mutating its sequence influenced the activity of CYPOR. It is likely that the analogous linker in other members of the diflavin family functions in a similar manner.

[1]  M. J. Coon,et al.  Kinetics of reduction of cytochrome P-450LM4 in a reconstituted liver microsomal enzyme system. , 1979, The Journal of biological chemistry.

[2]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[3]  M. J. Coon,et al.  Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. , 1981, The Journal of biological chemistry.

[4]  C. Kasper,et al.  Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase. , 2003, Biochemistry.

[5]  L. Waskell,et al.  Cytochrome b5 Increases the Rate of Product Formation by Cytochrome P450 2B4 and Competes with Cytochrome P450 Reductase for a Binding Site on Cytochrome P450 2B4* , 2007, Journal of Biological Chemistry.

[6]  R. Gray Kinetics and mechanism of carbon monoxide binding to purified liver microsomal cytochrome P-450 isozymes. , 1982, The Journal of biological chemistry.

[7]  M. Gerstein,et al.  The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework. , 2000, Nucleic acids research.

[8]  R. Banerjee,et al.  Human Methionine Synthase Reductase, a Soluble P-450 Reductase-like Dual Flavoprotein, Is Sufficient for NADPH-dependent Methionine Synthase Activation* , 2001, The Journal of Biological Chemistry.

[9]  C. Wolf,et al.  Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Christopher C. Moser,et al.  Natural engineering principles of electron tunnelling in biological oxidation–reduction , 1999, Nature.

[11]  H. Enoch,et al.  Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. , 1979, The Journal of biological chemistry.

[12]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[13]  S. Kelly,et al.  A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. , 2006, Structure.

[14]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[15]  M. J. Coon,et al.  Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. , 1982, The Journal of biological chemistry.

[16]  V. Blinov,et al.  Cytochrome C (Fe2+) as a competitive inhibitor of NADPH-dependent reduction of cytochrome P450 LM2: locating protein-protein interaction sites in microsomal electron carriers. , 1992, Archives of biochemistry and biophysics.

[17]  T. Iyanagi,et al.  Redox properties of the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 and reduced nicotinamide adenine dinucleotide-cytochrome b5 reductases. , 1974, Biochemistry.

[18]  G. Kurzban,et al.  Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase. , 1986, The Journal of biological chemistry.

[19]  Nico P E Vermeulen,et al.  Enzyme-Catalyzed Activation of Anticancer Prodrugs , 2004, Pharmacological Reviews.

[20]  G. Tollin,et al.  Laser flash photolysis studies of the reduction kinetics of NADPH:cytochrome P-450 reductase. , 1991, Biochemistry.

[21]  L. Waskell,et al.  Overexpression and purification of the membrane-bound cytochrome P450 2B4. , 2001, Protein expression and purification.

[22]  C. Kasper,et al.  Role of Acidic Residues in the Interaction of NADPH-Cytochrome P450 Oxidoreductase with Cytochrome P450 and Cytochrome c(*) , 1995, The Journal of Biological Chemistry.

[23]  C. Wolf,et al.  Cloning and Characterization of a Novel Human Dual Flavin Reductase* , 2000, The Journal of Biological Chemistry.

[24]  P. Dutton,et al.  Large scale domain movement in cytochrome bc(1): a new device for electron transfer in proteins. , 2001, Trends in biochemical sciences.

[25]  M. J. Coon,et al.  Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. , 1978, The Journal of biological chemistry.

[26]  Mark Gerstein,et al.  The Database of Macromolecular Motions: new features added at the decade mark , 2005, Nucleic Acids Res..

[27]  B. Horecker TRIPHOSPHOPYRIDINE NUCLEOTIDE-CYTOCHROME c REDUCTASE IN LIVER , 1950 .

[28]  M. Haque,et al.  A connecting hinge represses the activity of endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.

[29]  T. Poulos,et al.  Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Scrutton,et al.  Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding. , 2002, Biochemistry.

[31]  B. Masters,et al.  Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. , 1972, The Journal of biological chemistry.

[32]  C. Bonfils,et al.  Activation volume and energetic properties of the binding of CO to hemoproteins. , 1994, Biophysical journal.

[33]  Aaron D. Wilson,et al.  Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Zhiping Weng,et al.  Protein-protein docking: overview and performance analysis. , 2008, Methods in molecular biology.

[35]  C. Kasper,et al.  NADPH-Cytochrome P450 Oxidoreductase , 2001, The Journal of Biological Chemistry.

[36]  T. E. Wilson,et al.  Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. , 1989, The Journal of biological chemistry.

[37]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[38]  J. Tainer,et al.  Structural Basis for Isozyme-specific Regulation of Electron Transfer in Nitric-oxide Synthase*[boxs] , 2004, Journal of Biological Chemistry.

[39]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[40]  J. Schenkman,et al.  Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners. , 1986, Molecular pharmacology.

[41]  B. Masters,et al.  The history, properties, and function of NADPH-cytochrome P-450 reductase. , 1980, Pharmacology & therapeutics.

[42]  A. Gutiérrez,et al.  Conformational dynamics and the energetics of protein--ligand interactions: role of interdomain loop in human cytochrome P450 reductase. , 2007, Biochemistry.

[43]  Benveniste,et al.  Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.

[44]  A. Brunger Version 1.2 of the Crystallography and NMR system , 2007, Nature Protocols.

[45]  I. Vakser,et al.  Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b 5 and Cytochrome P450 Reductase* , 1998, The Journal of Biological Chemistry.

[46]  R. Hille,et al.  Differences in a Conformational Equilibrium Distinguish Catalysis by the Endothelial and Neuronal Nitric-oxide Synthase Flavoproteins* , 2008, Journal of Biological Chemistry.